Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
PUT
Transmedics
TMDX
$3B
| $29.8M | ﹤0.01% |
449,300
+353,900
| +371% | +$30M |
|
2077
PUT
Dick's Sporting Goods
DKS
$11B
| $29.8M | ﹤0.01% |
131,500
-9,400
| -7% | -$2.08M |
|
2078
Ouster
OUST
$2.52B
| $29.8M | ﹤0.01% |
476,586
+259,113
| +119% | +$8.72M |
|
2079
HEICO Corp Class A
HEI.A
$30.9B
| $29.8M | ﹤0.01% |
115,484
+29,226
| +34% | +$6.68M |
|
2080
Baidu
BIDU
$30.7B
| $29.8M | ﹤0.01% |
260,472
-115,700
| -31% | -$14.3M |
|
|
PURR
2081
PUT
Hyperliquid Strategies Inc
PURR
$2.54B
| $29.7M | ﹤0.01% |
3,778,900
+3,761,800
| +21,999% | +$27.8M |
|
2082
Motorola Solutions
MSI
$76.1B
| $29.7M | ﹤0.01% |
71,593
+1,171
| +2% | +$490K |
|
2083
CALL
Darden Restaurants
DRI
$23.5B
| $29.7M | ﹤0.01% |
144,200
-8,600
| -6% | -$1.72M |
|
|
NVMI
2084
CALL
Nova
NVMI
$11.1B
| $29.6M | ﹤0.01% |
54,500
+5,500
| +11% | +$2.83M |
|
2085
PUT
Sherwin-Williams
SHW
$77.9B
| $29.6M | ﹤0.01% |
85,900
+58,100
| +209% | +$18.6M |
|
2086
PUT
WIX.com
WIX
$3.34B
| $29.6M | ﹤0.01% |
651,800
+477,200
| +273% | +$29.5M |
|
2087
PUT
Rocket Companies
RKT
$35.6B
| $29.6M | ﹤0.01% |
1,877,291
+583,295
| +45% | +$8.41M |
|
|
ETOR
2088
eToro Group
ETOR
$2.22B
| $29.6M | ﹤0.01% |
749,047
+290,853
| +63% | +$11M |
|
2089
PUT
Nutrien
NTR
$37.7B
| $29.6M | ﹤0.01% |
469,600
-172,400
| -27% | -$12.1M |
|
2090
TG Therapeutics
TGTX
$8.64B
| $29.5M | ﹤0.01% |
537,170
-1,385,719
| -72% | -$56.7M |
|
2091
CALL
Coca-Cola Europacific Partners
CCEP
$44.3B
| $29.5M | ﹤0.01% |
294,900
-144,300
| -33% | -$13.8M |
|
2092
CALL
Royal Bank of Canada
RY
$282B
| $29.5M | ﹤0.01% |
142,500
| – | – |
|
2093
Hims & Hers Health
HIMS
$6.51B
| $29.4M | ﹤0.01% |
846,936
+152,162
| +22% | +$4.08M |
|
2094
Moody's
MCO
$80B
| $29.3M | ﹤0.01% |
64,798
-16,718
| -21% | -$7.51M |
|
2095
CALL
Canadian Natural Resources
CNQ
$104B
| $29.3M | ﹤0.01% |
742,600
-202,300
| -21% | -$9.2M |
|
2096
PENN Entertainment
PENN
$2.34B
| $29.3M | ﹤0.01% |
1,372,580
-1,198,172
| -47% | -$21.5M |
|
|
VG
2097
PUT
Venture Global Inc
VG
$36.1B
| $29.2M | ﹤0.01% |
2,627,800
+1,500,600
| +133% | +$19M |
|
2098
DXC Technology
DXC
$1.83B
| $29.2M | ﹤0.01% |
3,304,262
+940,654
| +40% | +$9.75M |
|
2099
Berkshire Hathaway Class A
BRK.A
$1.09T
| $29.2M | ﹤0.01% |
+39
| New | +$28.1M |
|
2100
CALL
Tapestry
TPR
$23.1B
| $29.2M | ﹤0.01% |
199,500
-65,600
| -25% | -$9.4M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.